Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
IssueQ22020
Sort By
Newest First
1 / 3
1 / 3
COVID-19
Rethinking Pharma’s Responsibilities in a Time of Crisis
Tim Tyson
TriRx Pharmaceutical Services
PAP-Q2-20-CL-001
Jul 01, 2020
Nice Insight Overview
Drug Approval Trends: Significant Acceleration in Recent Years
Nigel Walker
Nice Insight
PAP-Q2-20-NI-001
Jul 01, 2020
Industry Leader Insight
Accelerating COVID-19 Programs with Comprehensive Support from Cell Line to Commercial Production at a Single Site
Magnus Schroeder, Ph.D.
Avid Bioservices
PAP-Q2-20-CL-002
Jul 01, 2020
Chronokines
Delivering Breakthrough Medicines for Rare Hematologic Diseases and Cancers
Emilie Branch; Frank D. Lee
Pharma's Almanac
PAP-Q2-20-CL-003
Jul 01, 2020
Secure Validated Shipping
The Essentiality of Transportation to the Pharma Industry
Andrew Boyle
Boyle Transportation
PAP-Q2-20-CL-004
Jul 01, 2020
Fill-Finish Services
Avara Liscate: High Standards and Expertise in Sterile Manufacturing
Andrea Baiocchi
Avara Pharmaceutical Services
PAP-Q2-20-CL-005
Jul 01, 2020
CDMO
Positioning a CDMO to Meet Future Needs
Tyler Kerr; James Balog; Andrew Waaso
Albemarle Fine Chemistry Services
PAP-Q2-20-CL-006
Jul 01, 2020
Equipment
Common Challenges and Solutions of Equipment Ownership and Use
Matt Hicks
Federal Equipment Company
PAP-Q2-20-CL-007
Jul 01, 2020
Microbiome
Selecting a Microbiome CDMO Partner for the Long Term
Dave Stevens; Jason Rahal
Arranta Bio
PAP-Q2-20-CL-008
Jul 01, 2020
Integration
Creating Value through Best Practices Across a Global, Integrated Service Provider
Jeffrey Butler, Ph.D.
AMPAC Fine Chemicals
PAP-Q2-20-CL-009
Jul 01, 2020
Research Innovation
Leveraging Innovative Technologies to Access Better Data More Efficiently and Cost-Effectively
Lorraine Rusch, Ph.D.; J. Fred Pritchard, Ph.D.
Celerion
PAP-Q2-20-CL-010
Jul 01, 2020
Molecules
Molecules that Changed Medicine
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q2-20-NI-002
Jul 01, 2020
Aseptic Manufacturing
Aseptic Manufacturing with State-of-the-Art Technologies
Kurt R. Nielsen, Ph.D.
Pii
PAP-Q2-20-CL-011
Jul 01, 2020
Antibody–Drug Conjugates
Linking Novel Medicines to Patients with Hard-to-Treat Cancers for Improved Quality of Life
Loretta Itri, M.D., F.A.C.P.,; Usama Malik
Immunomedics
PAP-Q2-20-CL-012
Jul 01, 2020
Chronokines
Solving Unmet Clinical Needs by Harnessing the Science of Aging
Emilie Branch; Elizabeth Jeffords
Pharma's Almanac
PAP-Q2-20-CL-013
Jul 01, 2020
Cancer Therapies
Computational Discoveries for Clinical Development of Novel Cancer Therapies
David Alvaro, Ph.D.; Anat Cohen-Dayag, Ph.D.
Pharma's Almanac
PAP-Q2-20-CL-014
Jul 01, 2020
Biosynthesis
Redesigning Organisms as Metabolism Architects
Cyrille Pauthenier, Ph.D.; Filippo Giancarlo Martinelli, PDEng
Abolis
PAP-Q2-20-CL-015
Jul 01, 2020
Drug Repositioning
A Therapeutic Strategy for Neurological Disorders
Franck Mouthon; Mathieu Charvériat, Ph.D.
Theranexus
PAP-Q2-20-CL-016
Jul 01, 2020
Immunotherapy
Leveraging the Native Immune Response to Fight Cancer
Asher Nathan
NeoTX
PAP-Q2-20-CL-017
Jul 01, 2020
Immunotherapy
Applying the Principles of Immunotherapy to Infectious Diseases
Jeffrey Stein, Ph.D.
Cidara Therapeutics
PAP-Q2-20-CL-018
Jul 01, 2020
